| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $2.64 (Beat by $0.28) |
| EPS GAAP Actual | $2.64 (Beat by $0.28) |
| Revenue Actual | $0.996301B |
| Revenue Surprise | Beat by $996.301M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $3.88741 |
| EPS GAAP Estimate | $3.88741 |
| Revenue Estimate | $1.157927252B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 14.59 | 5.39 | 14.20462 | 14.95915 | 1 |
| Dec 2028 | 17.73 | 4.44 | 16.31968 | 18.35212 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.72 | -1.13979 | 0.996301B | -6.61% | -170.1M |
| FQ2 2025 (Jun 2025) | -8.79 | -12.61285 | 1.14937B | 3.29% | -11.64M |
| FQ1 2025 (Mar 2025) | 2.85 | 2.85 | 0.937333B | -0.14% | 937.33M |
| FQ4 2024 (Dec 2024) | 6.4 | 6.4 | 0.989773B | 3% | 989.77M |
| FQ3 2024 (Sep 2024) | 3.38 | 3.38 | 1.0622B | 1.55% | 1062.2M |
| FQ2 2024 (Jun 2024) | 3.79 | 3.79 | 1.1115B | 3.52% | 1111.5M |
| FQ1 2024 (Mar 2024) | 2.52 | 2.52 | 0.938633B | 5.8% | 938.63M |
| FQ4 2023 (Dec 2023) | 4.13 | 4.13 | 0.960097B | 1.56% | 960.1M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
3.88741
Consensus Revenue Estimates
1.157927252B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.6 | -- | 1.55671 | 1.6622 | 5 |
| FQ3 2027 (Sep 2027) | 3.81 | -- | 3.76409 | 3.86251 | 2 |
| FQ2 2027 (Jun 2027) | 4.16 | -- | 4.10987 | 4.21733 | 2 |
| FQ1 2027 (Mar 2027) | 2.59 | -- | 2.55879 | 2.6257 | 2 |
| FQ4 2026 (Oct 2026) | 4.28 | -- | 4.22505 | 4.32786 | 3 |
| FQ3 2026 (Jul 2026) | 4.07 | 33.17 | 4.01774 | 4.11551 | 5 |
| FQ2 2026 (Jun 2026) | 4.07 | 315.97 | 4.02579 | 4.14001 | 4 |
| FQ1 2026 (Mar 2026) | 2.57 | -10.89 | 2.54208 | 2.61421 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.38B | -- | 2.33B | 2.46B | 3 |
| FQ3 2027 (Sep 2027) | 1.04B | -- | 1.04B | 1.06B | 3 |
| FQ2 2027 (Jun 2027) | 1.12B | -- | 1.11B | 1.13B | 3 |
| FQ1 2027 (Mar 2027) | 1.18B | -- | 1.17B | 1.19B | 3 |
| FQ4 2026 (Oct 2026) | 1.18B | -- | 1.17B | 1.19B | 4 |
| FQ3 2026 (Jul 2026) | 1.19B | 16.16 | 1.18B | 1.2B | 5 |
| FQ2 2026 (Jun 2026) | 1.19B | 3.28 | 1.18B | 1.2B | 5 |
| FQ1 2026 (Mar 2026) | 0.94B | 0.04 | 0.93B | 0.95B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.85979 | 2.72 | -1.13979 | -41.9% |
| FQ2 2025 (Jun 2025) | 3.82285 | -8.79 | -12.61285 | 143.49% |
| FQ1 2025 (Mar 2025) | 2.85 | 2.85 | 100% | |
| FQ4 2024 (Dec 2024) | 6.4 | 6.4 | 100% | |
| FQ3 2024 (Sep 2024) | 3.38 | 3.38 | 100% | |
| FQ2 2024 (Jun 2024) | 3.79 | 3.79 | 100% | |
| FQ1 2024 (Mar 2024) | 2.52 | 2.52 | 100% | |
| FQ4 2023 (Dec 2023) | 4.13 | 4.13 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.17B | $1B | $-170.1M | -17.07% |
| FQ2 2025 (Jun 2025) | $1.16B | $1.15B | $-11.64M | -1.01% |
| FQ1 2025 (Mar 2025) | $0B | $0.94B | $937.33M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.99B | $989.77M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.06B | $1062.2M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.11B | $1111.5M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.94B | $938.63M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.96B | $960.1M | 100% |